Skip to main content
Top
Published in: Familial Cancer 3/2020

Open Access 01-07-2020 | Pancreatic Cancer | Original Article

Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance

Authors: Kasper A. Overbeek, Djuna L. Cahen, Anne Kamps, Ingrid C. A. W. Konings, Femme Harinck, Marianne A. Kuenen, Bas Groot Koerkamp, Marc G. Besselink, Casper H. van Eijck, Anja Wagner, Margreet G. E. Ausems, Manon van der Vlugt, Paul Fockens, Frank P. Vleggaar, Jan-Werner Poley, Jeanin E. van Hooft, Eveline M. A. Bleiker, Marco J. Bruno, the Dutch Familial Pancreatic Cancer Surveillance Study Group

Published in: Familial Cancer | Issue 3/2020

Login to get access

Abstract

In high-risk individuals participating in a pancreatic cancer surveillance program, worrisome features warrant for intensified surveillance or, occasionally, surgery. Our objectives were to determine the patient-reported burden of intensified surveillance and/or surgery, and to assess post-operative quality of life and opinion of surgery. Participants in our pancreatic cancer surveillance program completed questionnaires including the Cancer Worry Scale (CWS) and the Hospital Anxiety and Depression Scale (HADS). For individuals who underwent intensified surveillance, questionnaires before, during, and ≥ 3 weeks after were analyzed. In addition, subjects who underwent intensified surveillance in the past 3 years or underwent surgery at any time, were invited for an interview, that included the Short-Form 12 (SF-12). A total of 31 high-risk individuals were studied. During the intensified surveillance period, median CWS scores were higher (14, IQR 7), as compared to before (12, IQR 9, P = 0.007) and after (11, IQR 7, P = 0.014), but eventually returned back to baseline (P = 0.823). Median HADS scores were low: 5 (IQR 6) for anxiety and 3 (IQR 5) for depression, and they were unaffected by the intensified surveillance period. Of the 10 operated patients, 1 (10%) developed diabetes and 7 (70%) pancreatic exocrine insufficiency. The interviews yielded median quality-of-life scores comparable to the general population. Also, after surgery, patients’ attitudes towards surveillance were unchanged (5/10, 50%) or became more positive (4/10, 40%). Although patients were aware of the (sometimes benign) pathological outcome, when asked if surgery had been justified, only 20% (2/10) disagreed, and all would again have chosen to undergo surgery. In conclusion, in individuals at high risk for pancreatic cancer, intensified surveillance temporarily increased cancer worries, without affecting general anxiety or depression. Although pancreatic surgery led to substantial co-morbidity, quality of life was similar to the general population, and surgery did not negatively affect the attitude towards surveillance.
Appendix
Available only for authorised users
Literature
2.
go back to reference Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK, Bassi C, Carrato A, Farrell J, Fishman EK, Fockens P, Gress TM, van Hooft JE, Hruban RH, Kastrinos F, Klein A, Lennon AM, Lucas A, Park W, Rustgi A, Simeone D, Stoffel E, Vasen HFA, Cahen DL, Canto MI, Bruno M, International Cancer of the Pancreas Screening c (2019) Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. https://doi.org/10.1136/gutjnl-2019-319352 CrossRefPubMed Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK, Bassi C, Carrato A, Farrell J, Fishman EK, Fockens P, Gress TM, van Hooft JE, Hruban RH, Kastrinos F, Klein A, Lennon AM, Lucas A, Park W, Rustgi A, Simeone D, Stoffel E, Vasen HFA, Cahen DL, Canto MI, Bruno M, International Cancer of the Pancreas Screening c (2019) Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. https://​doi.​org/​10.​1136/​gutjnl-2019-319352 CrossRefPubMed
5.
go back to reference Canto MI, Almario JA, Schulick RD, Yeo CJ, Klein A, Blackford A, Shin EJ, Sanyal A, Yenokyan G, Lennon AM, Kamel IR, Fishman EK, Wolfgang C, Weiss M, Hruban RH, Goggins M (2018) Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance. Gastroenterology 155(3):740–751 e2. https://doi.org/10.1053/j.gastro.2018.05.035 CrossRefPubMed Canto MI, Almario JA, Schulick RD, Yeo CJ, Klein A, Blackford A, Shin EJ, Sanyal A, Yenokyan G, Lennon AM, Kamel IR, Fishman EK, Wolfgang C, Weiss M, Hruban RH, Goggins M (2018) Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance. Gastroenterology 155(3):740–751 e2. https://​doi.​org/​10.​1053/​j.​gastro.​2018.​05.​035 CrossRefPubMed
7.
go back to reference Bartsch DK, Slater EP, Carrato A, Ibrahim IS, Guillen-Ponce C, Vasen HF, Matthai E, Earl J, Jendryschek FS, Figiel J, Steinkamp M, Ramaswamy A, Vazquez-Sequeiros E, Munoz-Beltran M, Montans J, Mocci E, Bonsing BA, Wasser M, Kloppel G, Langer P, Fendrich V, Gress TM (2016) Refinement of screening for familial pancreatic cancer. Gut. https://doi.org/10.1136/gutjnl-2015-311098 CrossRefPubMed Bartsch DK, Slater EP, Carrato A, Ibrahim IS, Guillen-Ponce C, Vasen HF, Matthai E, Earl J, Jendryschek FS, Figiel J, Steinkamp M, Ramaswamy A, Vazquez-Sequeiros E, Munoz-Beltran M, Montans J, Mocci E, Bonsing BA, Wasser M, Kloppel G, Langer P, Fendrich V, Gress TM (2016) Refinement of screening for familial pancreatic cancer. Gut. https://​doi.​org/​10.​1136/​gutjnl-2015-311098 CrossRefPubMed
8.
go back to reference van Rijssen LB, Koerkamp BG, Zwart MJ, Bonsing BA, Bosscha K, van Dam RM, van Eijck CH, Gerhards MF, van der Harst E, de Hingh IH, de Jong KP, Kazemier G, Klaase J, van Laarhoven CJ, Molenaar IQ, Patijn GA, Rupert CG, van Santvoort HC, Scheepers JJ, van der Schelling GP, Busch OR, Besselink MG (2017) Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit. HPB (Oxford) 19(10):919–926. https://doi.org/10.1016/j.hpb.2017.06.010 CrossRef van Rijssen LB, Koerkamp BG, Zwart MJ, Bonsing BA, Bosscha K, van Dam RM, van Eijck CH, Gerhards MF, van der Harst E, de Hingh IH, de Jong KP, Kazemier G, Klaase J, van Laarhoven CJ, Molenaar IQ, Patijn GA, Rupert CG, van Santvoort HC, Scheepers JJ, van der Schelling GP, Busch OR, Besselink MG (2017) Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit. HPB (Oxford) 19(10):919–926. https://​doi.​org/​10.​1016/​j.​hpb.​2017.​06.​010 CrossRef
10.
go back to reference Cazacu IM, Luzuriaga Chavez AA, Saftoiu A, Bhutani MS (2018) Psychological impact of pancreatic cancer screening by EUS or magnetic resonance imaging in high-risk individuals: A systematic review. Endosc Ultrasound 8(1):17PubMedCentral Cazacu IM, Luzuriaga Chavez AA, Saftoiu A, Bhutani MS (2018) Psychological impact of pancreatic cancer screening by EUS or magnetic resonance imaging in high-risk individuals: A systematic review. Endosc Ultrasound 8(1):17PubMedCentral
11.
go back to reference Harinck F, Konings IC, Kluijt I, Poley JW, van Hooft JE, van Dullemen HM, Nio CY, Krak NC, Hermans JJ, Aalfs CM, Wagner A, Sijmons RH, Biermann K, van Eijck CH, Gouma DJ, Dijkgraaf MG, Fockens P, Bruno MJ, Drgopcsih-r I (2015) A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals. Gut. https://doi.org/10.1136/gutjnl-2014-308008 CrossRefPubMed Harinck F, Konings IC, Kluijt I, Poley JW, van Hooft JE, van Dullemen HM, Nio CY, Krak NC, Hermans JJ, Aalfs CM, Wagner A, Sijmons RH, Biermann K, van Eijck CH, Gouma DJ, Dijkgraaf MG, Fockens P, Bruno MJ, Drgopcsih-r I (2015) A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals. Gut. https://​doi.​org/​10.​1136/​gutjnl-2014-308008 CrossRefPubMed
12.
go back to reference Konings IC, Harinck F, Kuenen MA, Sidharta GN, Kieffer JM, Aalfs CM, Poley JW, Smets EM, Wagner A, van Rens A, Vleggaar FP, Ausems MG, Fockens P, van Hooft JE, Bruno MJ, Bleiker EM (2017) Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance. Fam Cancer 16(1):143–151. https://doi.org/10.1007/s10689-016-9930-4 CrossRefPubMed Konings IC, Harinck F, Kuenen MA, Sidharta GN, Kieffer JM, Aalfs CM, Poley JW, Smets EM, Wagner A, van Rens A, Vleggaar FP, Ausems MG, Fockens P, van Hooft JE, Bruno MJ, Bleiker EM (2017) Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance. Fam Cancer 16(1):143–151. https://​doi.​org/​10.​1007/​s10689-016-9930-4 CrossRefPubMed
13.
go back to reference Konings IC, Harinck F, Poley JW, Aalfs CM, van Rens A, Krak NC, Wagner A, Nio CY, Sijmons RH, van Dullemen HM, Vleggaar FP, Ausems MG, Fockens P, van Hooft JE, Bruno MJ (2017) Prevalence and progression of pancreatic cystic precursor lesions differ between groups at high risk of developing pancreatic cancer. Pancreas 46(1):28–34. https://doi.org/10.1097/mpa.0000000000000725 CrossRefPubMed Konings IC, Harinck F, Poley JW, Aalfs CM, van Rens A, Krak NC, Wagner A, Nio CY, Sijmons RH, van Dullemen HM, Vleggaar FP, Ausems MG, Fockens P, van Hooft JE, Bruno MJ (2017) Prevalence and progression of pancreatic cystic precursor lesions differ between groups at high risk of developing pancreatic cancer. Pancreas 46(1):28–34. https://​doi.​org/​10.​1097/​mpa.​0000000000000725​ CrossRefPubMed
15.
go back to reference Konings IC, Sidharta GN, Harinck F, Aalfs CM, Poley JW, Kieffer JM, Kuenen MA, Smets EM, Wagner A, van Hooft JE, van Rens A, Fockens P, Bruno MJ, Bleiker EM (2016) Repeated participation in pancreatic cancer surveillance by high-risk individuals imposes low psychological burden. Psychooncology 25(8):971–978. https://doi.org/10.1002/pon.4047 CrossRefPubMed Konings IC, Sidharta GN, Harinck F, Aalfs CM, Poley JW, Kieffer JM, Kuenen MA, Smets EM, Wagner A, van Hooft JE, van Rens A, Fockens P, Bruno MJ, Bleiker EM (2016) Repeated participation in pancreatic cancer surveillance by high-risk individuals imposes low psychological burden. Psychooncology 25(8):971–978. https://​doi.​org/​10.​1002/​pon.​4047 CrossRefPubMed
19.
go back to reference Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed
20.
go back to reference Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM (1997) A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 27(2):363–370CrossRefPubMed Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM (1997) A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 27(2):363–370CrossRefPubMed
21.
go back to reference Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res 52(2):69–77CrossRefPubMed Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res 52(2):69–77CrossRefPubMed
23.
go back to reference Ware J Jr, Kosinski M, Keller SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34(3):220–233CrossRefPubMed Ware J Jr, Kosinski M, Keller SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34(3):220–233CrossRefPubMed
25.
go back to reference Ware JEJ, Kosinski M, Keller SD (1995) How to score the SF-12 physical and mental health summary scales. The Health Institute, New England Medical Center, Boston Ware JEJ, Kosinski M, Keller SD (1995) How to score the SF-12 physical and mental health summary scales. The Health Institute, New England Medical Center, Boston
27.
go back to reference Barratt AL (2006) Cancer screening–benefits, harms and making an informed choice. Aust Fam Physician 35(1–2):39–42PubMed Barratt AL (2006) Cancer screening–benefits, harms and making an informed choice. Aust Fam Physician 35(1–2):39–42PubMed
30.
go back to reference Hart SL, Torbit LA, Crangle CJ, Esplen MJ, Holter S, Semotiuk K, Borgida A, Ardiles P, Rothenmund H, Gallinger S (2012) Moderators of cancer-related distress and worry after a pancreatic cancer genetic counseling and screening intervention. Psychooncology 21(12):1324–1330. https://doi.org/10.1002/pon.2026 CrossRefPubMed Hart SL, Torbit LA, Crangle CJ, Esplen MJ, Holter S, Semotiuk K, Borgida A, Ardiles P, Rothenmund H, Gallinger S (2012) Moderators of cancer-related distress and worry after a pancreatic cancer genetic counseling and screening intervention. Psychooncology 21(12):1324–1330. https://​doi.​org/​10.​1002/​pon.​2026 CrossRefPubMed
33.
go back to reference Festinger L (1957) A theory of cognitive dissonance. Stanford University Press, Stanford Festinger L (1957) A theory of cognitive dissonance. Stanford University Press, Stanford
34.
go back to reference Cooper J (1971) Personal responsibility and dissonance: the role of foreseen consequences. J Pers Soc Psychol 18(3):354–363CrossRef Cooper J (1971) Personal responsibility and dissonance: the role of foreseen consequences. J Pers Soc Psychol 18(3):354–363CrossRef
38.
go back to reference Huang JJ, Yeo CJ, Sohn TA, Lillemoe KD, Sauter PK, Coleman J, Hruban RH, Cameron JL (2000) Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg 231(6):890–898CrossRefPubMedPubMedCentral Huang JJ, Yeo CJ, Sohn TA, Lillemoe KD, Sauter PK, Coleman J, Hruban RH, Cameron JL (2000) Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg 231(6):890–898CrossRefPubMedPubMedCentral
Metadata
Title
Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance
Authors
Kasper A. Overbeek
Djuna L. Cahen
Anne Kamps
Ingrid C. A. W. Konings
Femme Harinck
Marianne A. Kuenen
Bas Groot Koerkamp
Marc G. Besselink
Casper H. van Eijck
Anja Wagner
Margreet G. E. Ausems
Manon van der Vlugt
Paul Fockens
Frank P. Vleggaar
Jan-Werner Poley
Jeanin E. van Hooft
Eveline M. A. Bleiker
Marco J. Bruno
the Dutch Familial Pancreatic Cancer Surveillance Study Group
Publication date
01-07-2020
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 3/2020
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-020-00171-8

Other articles of this Issue 3/2020

Familial Cancer 3/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine